Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
NA
77 participants
INTERVENTIONAL
2015-02-28
2016-07-31
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Generalized Fear Extinction to Untreated Fear Stimuli in Specific Phobias After Exposure
NCT03907345
Optimizing Exposure Using Occasional Aversive Imagery in Spider Fearful Individuals
NCT05424250
The Role of Treatment Expectation in Exposure Training With Spider Fearful Participants
NCT03012035
The Effects of Safety Seeking Behaviors During Exposure Therapy for Adults With Spider Phobia
NCT03233113
Effects of Stress on Exposure Therapy
NCT03505437
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Patients with spider phobia will either receive two sessions of in-vivo exposure with spiders or no treatment. Prior to as well as after treatment, patient's fear of spiders will be assessed using the Behavioral Approach Test (BATs) and self-report questionnaires. In addition, BATs with cockroaches will be conducted to examine the effects of exposure therapy on extinction generalization.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
RANDOMIZED
PARALLEL
TREATMENT
NONE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Exposure Treatment
Participants of this arm receive two 60-minute sessions of exposure treatment for spider fear
Exposure treatment for spider fear
Two sessions (each session = 60 minutes) of in-vivo exposure treatment (including psychoeducation) with two different spiders. Exposures comprise a hierarchy of 7 steps, to be completed with both spiders.
No Exposure Treatment
Participants of this arm receive no exposure or other adequate treatment
No interventions assigned to this group
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Exposure treatment for spider fear
Two sessions (each session = 60 minutes) of in-vivo exposure treatment (including psychoeducation) with two different spiders. Exposures comprise a hierarchy of 7 steps, to be completed with both spiders.
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
Exclusion Criteria
* current behavioral or pharmacological treatment
* any mental disorder that is considered more severe than specific phobia
18 Years
65 Years
ALL
No
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Ruhr University of Bochum
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Armin Zlomuzica
Dr.
Principal Investigators
Learn about the lead researchers overseeing the trial and their institutional affiliations.
Armin Zlomuzica, Dr.
Role: PRINCIPAL_INVESTIGATOR
Ruhr University of Bochum
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
ZL 59/2-2
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.